Kairos Pharma KAPA Ratios (2023-2025)

NYSE KAPA
$0.60 +0.02 (+2.71%)
As of: Oct 21, 2026 · 3:59 PM EDT
Reported Financials

Kairos Pharma Quarterly Ratios

Periods 9 quarters
Latest Dec 2025

Kairos Pharma ratios data for the quarter ended Dec 2025. These financial ratios cover 9 quarters of results from Sep 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Dec2025
Profitability
EBT Margin -1.26%
EBIT Margin -1.27%
Operating Margin -1.27%
Net Margin -1.26%
FCF Margin -0.71%
Efficiency
Assets AverageAssets Avg. 5.39M6.85M7.31M6.61M
Equity AverageEquity Avg. -1.98M-2.24M-2.53M0.34M4.05M5.95M6.56M6.17M
Invested CapitalInvested Cap. 4.12M
Leverage & Solvency
Interest Coverage RatioInterest Cover -19.13-363.00-17.94-18.50-31.92
Debt Ratio 0.16
Times Interest Earned -19.13-363.00-17.94-18.50-31.92
Valuation
Price to BookP/B 42.3725.3014.5314.6816.32
Enterprise Value 137.97M119.56M100.04M84.98M98.99M
Market Capitalization 141.19M120.83M103.65M88.01M103.48M
Return Ratios
Return on Sales [ROS]ROS -1.27%
Return on Capital Employed [ROCE]ROCE -53.21%-54.85%-68.65%
Return on Assets [ROA]ROA -44.15%-48.70%-61.94%
Return on Equity [ROE]ROE -597.05%-58.66%-56.05%-68.93%

Kairos Pharma Ratios API

Pull Kairos Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KAPA&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY